SG Americas Securities LLC Takes Position in Astera Labs, Inc. $ALAB

SG Americas Securities LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 20,631 shares of the company’s stock, valued at approximately $4,040,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hoey Investments Inc. grew its holdings in Astera Labs by 22.4% during the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after acquiring an additional 1,121 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Astera Labs by 21.6% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after purchasing an additional 2,624 shares during the last quarter. Wealth Effects LLC acquired a new stake in shares of Astera Labs during the second quarter worth $242,000. Maryland State Retirement & Pension System grew its stake in shares of Astera Labs by 37.7% during the second quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock worth $629,000 after purchasing an additional 1,906 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Astera Labs by 94.6% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after purchasing an additional 53,276 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ALAB. Roth Capital raised their target price on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Morgan Stanley reissued an “overweight” rating and set a $210.00 price objective on shares of Astera Labs in a research note on Wednesday, December 3rd. Northland Securities boosted their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Bank of America began coverage on shares of Astera Labs in a report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price on the stock. Finally, TD Cowen decreased their price target on shares of Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $188.17.

Insider Activity at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 4,620 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the sale, the general counsel owned 147,040 shares in the company, valued at approximately $21,275,217.60. The trade was a 3.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This trade represents a 4.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 576,936 shares of company stock valued at $87,409,540 over the last ninety days. Company insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $162.61 on Monday. The firm has a market cap of $27.47 billion, a P/E ratio of 146.50, a PEG ratio of 2.22 and a beta of 1.50. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The firm’s 50 day moving average price is $159.79 and its two-hundred day moving average price is $163.85.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period last year, the business posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.